Literature DB >> 16389582

[Treatment resistant schizophrenia, residual subtype: symptom improvement after additional treatment with amisulpride].

Karsten Wolf1, Stefan Veismann, Guntram Knecht, Dieter Naber.   

Abstract

BACKGROUND: Therapy resistant, severe residual schizophrenia poses major challenges for the psychiatric pharmacological treatment.
METHOD: We report about a 44-year old schizophrenic male who has been detained in a closed forensic ward for 10 years, following a conviction in one manslaughter case. Despite various pharmacological treatment efforts severe residual schizophrenia remained. RESULT: Adding Amisulpride to the ongoing treatment with Olanzapine achieved a noticeable improvement of symptoms, resulting in the possibility of relaxing imprisonment conditions.
CONCLUSION: A combination of Amisulpride and Olanzapine seems to be effective in treating severe residual schizophrenia.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16389582     DOI: 10.1055/s-2003-814854

Source DB:  PubMed          Journal:  Psychiatr Prax        ISSN: 0303-4259


  1 in total

1.  Impact of DSM-5 changes on the diagnosis and acute treatment of schizophrenia.

Authors:  Taina Mattila; Maarten Koeter; Tamar Wohlfarth; Jitschak Storosum; Wim van den Brink; Lieuwe de Haan; Eske Derks; Hubertus Leufkens; Damiaan Denys
Journal:  Schizophr Bull       Date:  2014-12-20       Impact factor: 9.306

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.